Egis Pharmaceuticals made a net profit of HUF 18,531 mil with revenues of HUF 132,825 mil in 2012, up by 36.4% and up by 3.01%, respectively, compared to the previous year.
This translates into a net margin of 14.0%. Historically, between 2000 and 2012, the firm’s net margin reached a high of 15.2% in 2006 and a low of 6.50% in 2007. The average net margin in the last five years amounted to 12.3%.
On the operating level, the EBITDA margin reached 23.0% and EBIT amounted to 15.4% of sales in 2012.
You can see all the company’s data at Egis Pharmaceuticals profile, or you can download a report on the company in the report section.
Helgi Library 
